Management of Acute Embolic Stroke with IV Alteplase and Mechanical Thrombectomy
For acute embolic stroke, immediately administer IV alteplase (0.9 mg/kg, max 90 mg) within 3-4.5 hours of symptom onset if eligible, and proceed directly to mechanical thrombectomy for large vessel occlusion—do not delay thrombectomy to give alteplase. Time is brain, and both treatments should be initiated as rapidly as possible 1.
IV Alteplase: Time Windows and Eligibility
0-3 Hour Window (Class I, LOE A)
- Administer alteplase to ALL eligible patients regardless of age (<80 or >80 years) or stroke severity 1
- Even severe strokes benefit despite higher hemorrhagic transformation risk
- Blood pressure must be safely lowered to <185/110 mmHg before treatment
- Glucose must be >50 mg/dL
3-4.5 Hour Window (Class I, LOE B-R)
Alteplase is indicated BUT exclude patients with:
- Age >80 years
- NIHSS >25
- History of BOTH diabetes AND prior stroke
- Imaging showing >1/3 MCA territory involvement
- Current oral anticoagulant use 1
Extended Window (4.5-9 hours)
Recent European guidelines support treatment in selected patients using MRI DWI-FLAIR mismatch or perfusion imaging, particularly for wake-up strokes 2. However, the 2018 AHA/ASA guidelines do not recommend treatment beyond 4.5 hours for unclear onset times 1.
Mechanical Thrombectomy: Patient Selection
0-6 Hour Window (Class I, LOE A)
Perform thrombectomy PLUS best medical management (including IV alteplase when indicated) for large vessel occlusion 3. This combination improves functional outcomes with high-quality evidence.
6-24 Hour Window (Class I, LOE B-R)
Thrombectomy is recommended when patients meet specific imaging criteria showing salvageable brain tissue 3. Advanced imaging identifying penumbra is necessary for patient selection in this extended window.
Critical point: Even with large infarct cores, recent evidence suggests thrombectomy can improve outcomes in carefully selected patients 3, 4.
The Alteplase-Before-Thrombectomy Question
This is evolving. The DIRECT-MT trial showed thrombectomy alone was noninferior to combined therapy within a 20% margin 5. However:
- Combined therapy achieved higher rates of successful reperfusion (84.5% vs 79.4%)
- Pre-thrombectomy recanalization occurred more often with alteplase (7.0% vs 2.4%)
- Within the 4.5-hour window, both should be combined unless contraindications exist 6
The key is DO NOT DELAY thrombectomy to administer alteplase—these should proceed in parallel.
Special Populations
Prior Antiplatelet/Anticoagulant Use
- Single or dual antiplatelet therapy is NOT a contraindication to alteplase (Class I) 1
- Benefits outweigh the slightly increased symptomatic ICH risk
- Recent data suggest thrombectomy can be performed safely regardless of antithrombotic status 7
- Avoid antithrombotic therapy for 24 hours post-alteplase unless compelling indication exists (Class IIb) 1
Elderly Patients (>80 years)
- Age alone should NEVER exclude treatment 4
- Within 3 hours: treat with alteplase regardless of age (Class I) 1
- Within 3-4.5 hours: age >80 is an exclusion criterion for alteplase
- Thrombectomy benefits all age groups with large vessel occlusion 3, 4
- Base decisions on pre-stroke functional status (mRS), frailty, and goals of care—not chronological age
End-Stage Renal Disease
Alteplase is recommended in hemodialysis patients with normal aPTT (Class I) 1
Absolute Contraindications to Alteplase
- Intracranial hemorrhage on CT (Class III: Harm) 1
- Extensive hypoattenuation (obvious hypodensity representing irreversible injury) (Class III: No Benefit) 1
- Ischemic stroke within prior 3 months (Class III: Harm) 1
- Severe head trauma within 3 months (Class III: Harm) 1
- Time last known well >3 or 4.5 hours (Class III: No Benefit) 1
Post-Treatment Management
- Maintain BP <180/105 mmHg for 24 hours post-alteplase (Class I) 1
- Monitor for orolingual angioedema (alteplase-specific complication)
- Avoid antithrombotic therapy for 24 hours unless compelling indication
- Assess for symptomatic ICH if neurological deterioration occurs
Common Pitfalls to Avoid
- Delaying thrombectomy to complete alteplase infusion—start both simultaneously
- Using age >80 as blanket exclusion—only applies to 3-4.5 hour window for alteplase, not thrombectomy
- Withholding treatment due to antiplatelet use—this is explicitly recommended as safe
- Applying vigorous suction or excessive pressure during catheter assessment—can cause vascular damage
- Missing the extended window opportunity—patients 6-24 hours out may still benefit from thrombectomy with appropriate imaging selection
The evidence strongly supports aggressive, time-sensitive reperfusion therapy. Every 15-minute delay in treatment worsens outcomes—establish and follow institutional protocols to minimize door-to-needle and door-to-puncture times 1, 3.